[2] Ohsugi T , Yamaguchi K, Kumasaka T ,et al. Rapid tumor death model for evaluation of new therapeutic agents for adult T?cell leukemia [J].Lab Invest, 2004, 84 (2): 263? 266.
[3] Ninomiya M, Kiyoi H, Ito M,et al. Retinoic acid syndrome in NOD/ scid mice induced by injecting an acute promyelocytic leukemia cell line[J]. Leukemia, 2004, 18 (3): 442? 448.
[4] Pearson T, Greiner DL, Shultz LD. Humanized SCID mouse models for biomedical research[J].Curr Top Microbiol Immunol,2008, 324: 25?51.
[5] Pearson T, Greiner DL, Shultz LD. Creation of “humanized” mice to study human immunity [J].Curr Protoc Immunol,2008,Chapter 15: Unit 15.21.
[6] Arditti FD, Rabinkov A, Miron T,et al. Apoptotic killing of B?chronic lymphocytic leukemia tumor cells by allicin generated in situ using a rituximab?alliinase conjugates[J].Mol Cancer Ther, 2005, 4 (2): 325?331.
[7] Norén?Nystr?m U, Eriksson M, Eriksson B,et al. Anti?tumor activity of the angiogenesis inhibitor TNP?470 on murine lymphoma? leukemia cells in vivo and in vitro[J]. Exp Hematol, 2003, 31 (2): 143?149.
[8] Feuring?Buske M, Gerhard B, Cashman J,et al.Improved engraftment of human acute myeloid leukemia progenitor cells in beta?2 microglobulin deficient NOD/ SCID mice transgenic for human growth factors[J].Leukemia, 2003, 17 (4):760?763.
[9] Ramshaw HS, Bardy PG, Lee MA, et al.Chronic myelomonocytic leukemia require granulocyte?macrophage colony?stimulating factor for growth in vitro and in vivo[J].Exp Hematol, 2002, 30(10):1124?1131.
[10] Nicolini FE, Cashman JD, Hogge DE,et al.NOD/SCID mice engineered to express human IL?3, GM?CSF and Steel factor constitutively mobilize engrafted human progenitors and compromise human stem cell regeneration[J].Leukemia, 2004, 18(2):341?347.
[11] Niclou SP, Danzeisen C, Eikesdal HP,et al.A novel eGFP?expressing immunodeficient mouse model to study tumor?host interactions [J].FASEB J. 2008[Epub ahead of print].
百度搜索“77cn”或“免费范文网”即可找到本站免费阅读全部范文。收藏本站方便下次阅读,免费范文网,提供经典小说医药类免疫缺陷小鼠在白血病研究中的新进展(4)在线全文阅读。
相关推荐: